Literature DB >> 29695402

EGFR L861Q Mutation in a Metastatic Solid-pseudopapillary Neoplasm of the Pancreas.

Kevin G Neill1, James Saller1, Sameer Al Diffalha1, Barbara A Centeno1,2, Mokenge P Malafa3, Domenico Coppola4,2,5,6.   

Abstract

Solid-pseudopapillary neoplasm of the pancreas (SPN) is a rare neoplasm that is typically indolent in nature. Surgical resection is the preferred method of treatment and often associated with a good prognosis. Local invasion and metastasis have been reported in a small subset of patients. Currently, there are limited data on the molecular mutation profile of invasive and metastatic SPN. In this report, we present the case of a 38-year-old female with a locally-invasive and unresectable SPN that, despite exhaustive chemoradiotherapy, progressed to liver metastasis. Pyrosequencing of the primary pancreatic tumor antecedent to metastasis showed an uncommon EGFR mutation at L861Q in the kinase domain of exon 21. This finding, if confirmed in additional cases of metastatic SPN, would support preoperative testing for EGFR mutation analysis to detect aggressive SPNs. Copyright
© 2018, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.

Entities:  

Keywords:  EGFR; L861Q; Solid-pseudo-papillary; neoplasm; pancreas

Mesh:

Substances:

Year:  2018        PMID: 29695402      PMCID: PMC5971012          DOI: 10.21873/cgp.20078

Source DB:  PubMed          Journal:  Cancer Genomics Proteomics        ISSN: 1109-6535            Impact factor:   4.069


  23 in total

1.  Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal.

Authors:  Jianjiong Gao; Bülent Arman Aksoy; Ugur Dogrusoz; Gideon Dresdner; Benjamin Gross; S Onur Sumer; Yichao Sun; Anders Jacobsen; Rileen Sinha; Erik Larsson; Ethan Cerami; Chris Sander; Nikolaus Schultz
Journal:  Sci Signal       Date:  2013-04-02       Impact factor: 8.192

2.  Peritoneal carcinomatosis from solid pseudopapillary neoplasm (Frantz's tumour) of the pancreas treated with HIPEC.

Authors:  C Honore; D Goere; P Dartigues; P Burtin; F Dumont; D Elias
Journal:  Anticancer Res       Date:  2012-03       Impact factor: 2.480

3.  Effectiveness of Tyrosine Kinase Inhibitors in Japanese Patients with Non-small Cell Lung Cancer Harboring Minor Epidermal Growth Factor Receptor Mutations: Results from a Multicenter Retrospective Study (HANSHIN Oncology Group 0212).

Authors:  Tomoyuki Otsuka; Masahide Mori; Yukihiro Yano; Junji Uchida; Kazumi Nishino; Reiko Kaji; Akito Hata; Yoshihiro Hattori; Yoshiko Urata; Toshihiko Kaneda; Motoko Tachihara; Fumio Imamura; Nobuyuki Katakami; Shunichi Negoro; Satoshi Morita; Soichiro Yokota
Journal:  Anticancer Res       Date:  2015-07       Impact factor: 2.480

4.  EGFR L861Q mutation is a frequent feature of pulmonary mucoepidermoid carcinoma.

Authors:  Yongfeng Yu; Zhengbo Song; Hui Gao; Lei Zhu; Shun Lu; Jie Zhang; Qingquan Luo
Journal:  J Cancer Res Clin Oncol       Date:  2012-04-18       Impact factor: 4.553

5.  Gene expression profiling provides insights into the pathways involved in solid pseudopapillary neoplasm of the pancreas.

Authors:  Catherine Cavard; Anne Audebourg; Franck Letourneur; Virginie Audard; Frédéric Beuvon; Nicolas Cagnard; Brigitte Radenen; Pascale Varlet; Marie-Cécile Vacher-Lavenu; Christine Perret; Benoit Terris
Journal:  J Pathol       Date:  2009-06       Impact factor: 7.996

6.  Solid pseudopapillary tumor of the pancreas with liver metastasis: Clinical features and management.

Authors:  Wei-Bin Wang; Tai-Ping Zhang; Meng-Qing Sun; Zheng Peng; Ge Chen; Yu-Pei Zhao
Journal:  Eur J Surg Oncol       Date:  2014-06-12       Impact factor: 4.424

7.  Aggressive behaviour of solid-pseudopapillary tumor of the pancreas in adults: a case report and review of the literature.

Authors:  Cosimo Sperti; Mattia Berselli; Claudio Pasquali; Davide Pastorelli; Sergio Pedrazzoli
Journal:  World J Gastroenterol       Date:  2008-02-14       Impact factor: 5.742

8.  Effectiveness of gefitinib against non-small-cell lung cancer with the uncommon EGFR mutations G719X and L861Q.

Authors:  Satoshi Watanabe; Yuji Minegishi; Hirohisa Yoshizawa; Makoto Maemondo; Akira Inoue; Shunichi Sugawara; Hiroshi Isobe; Masao Harada; Yoshiki Ishii; Akihiko Gemma; Koichi Hagiwara; Kunihiko Kobayashi
Journal:  J Thorac Oncol       Date:  2014-02       Impact factor: 15.609

9.  Sensitivities to various epidermal growth factor receptor-tyrosine kinase inhibitors of uncommon epidermal growth factor receptor mutations L861Q and S768I: What is the optimal epidermal growth factor receptor-tyrosine kinase inhibitor?

Authors:  Eri Banno; Yosuke Togashi; Yu Nakamura; Masato Chiba; Yoshihisa Kobayashi; Hidetoshi Hayashi; Masato Terashima; Marco A de Velasco; Kazuko Sakai; Yoshihiko Fujita; Tetsuya Mitsudomi; Kazuto Nishio
Journal:  Cancer Sci       Date:  2016-07-14       Impact factor: 6.716

Review 10.  Surgical and molecular pathology of pancreatic neoplasms.

Authors:  Wenzel M Hackeng; Ralph H Hruban; G Johan A Offerhaus; Lodewijk A A Brosens
Journal:  Diagn Pathol       Date:  2016-06-07       Impact factor: 2.644

View more
  3 in total

Review 1.  Solid-pseudopapillary Neoplasms of the Pancreas is still an Enigma: a Clinicopathological Review.

Authors:  Attila Zalatnai; Viktória Kis-Orha
Journal:  Pathol Oncol Res       Date:  2019-06-17       Impact factor: 3.201

2.  Pathological Mechanistic Studies of Osimertinib Resistance in Non-Small-Cell Lung Cancer Cells Using an Integrative Metabolomics-Proteomics Analysis.

Authors:  Qing Ma; Jing Wang; Yaoyao Ren; Fanlu Meng; Lili Zeng
Journal:  J Oncol       Date:  2020-03-17       Impact factor: 4.375

Review 3.  Potential of modern circulating cell-free DNA diagnostic tools for detection of specific tumour cells in clinical practice.

Authors:  Jernej Gašperšič; Alja Videtič Paska
Journal:  Biochem Med (Zagreb)       Date:  2020-08-05       Impact factor: 2.313

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.